drugset / Trial / NCT03302741

Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings

NCT03302741

Non-randomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate if it is possible to use a new 3D imaging method to guide Botulinum neurotoxin (BTX) injection for muscle spasticity management after stroke. This imaging method is called three dimensional innervation zone imaging, or 3DIZI.

Timeline

Start
2017-11-21
Primary completion
2019-11-18
Completion
2019-11-18

Drugs

EvaluationDrugModalityDoseRoute
Background Botulinum toxin Protein / enzyme biologic 100 iu

Indications

No indication recorded.